Option Care Health (NASDAQ:OPCH) Downgraded by Jefferies Financial Group to Hold

Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by equities research analysts at Jefferies Financial Group from a "buy" rating to a "hold" rating in a report issued on Thursday, Marketbeat reports. They currently have a $26.00 price target on the stock, down from their prior price target of $38.00. Jefferies Financial Group's price target indicates a potential upside of 12.85% from the company's previous close.

OPCH has been the subject of several other reports. Bank of America lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the company from $43.00 to $29.00 in a report on Wednesday. Barrington Research reaffirmed an "outperform" rating and issued a $40.00 target price on shares of Option Care Health in a report on Wednesday, October 23rd. Finally, JMP Securities upped their target price on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th.

Option Care Health Stock Down 2.2 %

OPCH traded down $0.51 during midday trading on Thursday, reaching $23.04. 5,174,544 shares of the company were exchanged, compared to its average volume of 1,446,165. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The company's fifty day moving average price is $30.65 and its 200 day moving average price is $29.97. The company has a market cap of $3.94 billion, a price-to-earnings ratio of 19.36, a price-to-earnings-growth ratio of 2.31 and a beta of 1.29. Option Care Health has a one year low of $22.84 and a one year high of $34.63.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.22 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. As a group, analysts expect that Option Care Health will post 1.22 EPS for the current year.

Insider Activity at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the company's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the company's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the company's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. lifted its position in shares of Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company's stock worth $2,670,000 after acquiring an additional 73,312 shares in the last quarter. Comerica Bank lifted its position in shares of Option Care Health by 6.5% during the first quarter. Comerica Bank now owns 760,915 shares of the company's stock worth $25,521,000 after acquiring an additional 46,639 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company's stock worth $7,617,000 after purchasing an additional 146,837 shares during the period. Edgestream Partners L.P. increased its holdings in shares of Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company's stock worth $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, XTX Topco Ltd bought a new position in shares of Option Care Health in the second quarter worth $973,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.